Literature DB >> 6512830

A study of retinitis pigmentosa in the City of Birmingham. II Clinical and genetic heterogeneity.

S Bundey, S J Crews.   

Abstract

This is a study of 138 index patients with retinitis pigmentosa (RP) and their families, in which the selection of index patients was solely on the basis of their residence in Birmingham. Clinical analysis showed that severe disease was as likely to indicate dominant or non-genetic RP as to indicate recessive disease, and that each of three genetic types of uncomplicated RP could probably be divided into two entities. Autosomal dominant RP accounted for at least 22% of index patients but this was likely to be an underestimate because of the low penetrance of the disease. Autosomal recessive disease accounted for not more than 10% of index patients and its rarity was indicated by a high consanguinity rate. Recognisable X linked disease occurred in about 14% of index patients, a similar figure to other studies. The 37% of patients with uncomplicated RP and no obviously affected relative have either autosomal dominant RP or non-genetic RP; it is difficult to know the relative proportions of each. The risks for descendants of patients with recessive disease are clear. The risks of symptomatic RP in the offspring of patients who do, or who might have, dominant RP range from 1 in 2 to 1 in 37 according to the family history and the severity of the RP.

Entities:  

Mesh:

Year:  1984        PMID: 6512830      PMCID: PMC1049341          DOI: 10.1136/jmg.21.6.421

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  [Preliminary results of a survey on the incidence and geographic distribution of tapeto-retinal degeneration in Switzerland (study of 5 cantons)].

Authors:  F AMMANN; D KLEIN; H R BOHRINGER
Journal:  J Genet Hum       Date:  1961-07

2.  X-linked retinitis pigmentosa.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

3.  Sex-linked myopic chorioretinal heredodegeneration.

Authors:  J François; A De Rouck
Journal:  Am J Ophthalmol       Date:  1965-10       Impact factor: 5.258

4.  Rod and cone activity in patients with dominantly inherited retinitis pigmentosa: comparisons between psychophysical and electroretinographic measurements.

Authors:  G B Arden; R M Carter; C R Hogg; D J Powell; W J Ernst; G M Clover; A L Lyness; M P Quinlan
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

5.  Genetic aspects of retinitis pigmentosa in China.

Authors:  D N Hu
Journal:  Am J Med Genet       Date:  1982-05

6.  On the heredity of retinitis pigmentosa.

Authors:  M Jay
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

7.  A genetic analysis of retinitis pigmentosa.

Authors:  J A Boughman; G A Fishman
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

8.  Population genetic studies of retinitis pigmentosa.

Authors:  J A Boughman; P M Conneally; W E Nance
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

  8 in total
  23 in total

1.  Autosomal dominant retinitis pigmentosa (ADRP): a rhodopsin mutation in a Scottish family.

Authors:  C Bell; C A Converse; M F Collins; L Esakowitz; K F Kelly; N E Haites
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Nine generations of a family with autosomal dominant retinitis pigmentosa and evidence of variable expressivity from census records.

Authors:  M Jay; A C Bird; A N Moore; B Jay
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

3.  Clinical and genetic heterogeneity in retinitis pigmentosa.

Authors:  J Kaplan; D Bonneau; J Frézal; A Munnich; J L Dufier
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

4.  Genetic localisation of the RP2 type of X linked retinitis pigmentosa in a large kindred.

Authors:  A F Wright; S S Bhattacharya; M A Aldred; M Jay; A D Carothers; N S Thomas; A C Bird; B Jay; H J Evans
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

5.  Linkage to D3S47 (C17) in one large autosomal dominant retinitis pigmentosa family and exclusion in another: confirmation of genetic heterogeneity.

Authors:  D H Lester; C F Inglehearn; R Bashir; H Ackford; L Esakowitz; M Jay; A C Bird; A F Wright; S S Papiha; S S Bhattacharya
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

Review 6.  Brain Machine Interfaces for Vision Restoration: The Current State of Cortical Visual Prosthetics.

Authors:  Soroush Niketeghad; Nader Pouratian
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

7.  Mutations in IMPG2, encoding interphotoreceptor matrix proteoglycan 2, cause autosomal-recessive retinitis pigmentosa.

Authors:  Dikla Bandah-Rozenfeld; Rob W J Collin; Eyal Banin; L Ingeborgh van den Born; Karlien L M Coene; Anna M Siemiatkowska; Lina Zelinger; Muhammad I Khan; Dirk J Lefeber; Inbar Erdinest; Francesco Testa; Francesca Simonelli; Krysta Voesenek; Ellen A W Blokland; Tim M Strom; Caroline C W Klaver; Raheel Qamar; Sandro Banfi; Frans P M Cremers; Dror Sharon; Anneke I den Hollander
Journal:  Am J Hum Genet       Date:  2010-07-30       Impact factor: 11.025

8.  Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.

Authors:  Prasanthi Namburi; Rinki Ratnapriya; Samer Khateb; Csilla H Lazar; Yael Kinarty; Alexey Obolensky; Inbar Erdinest; Devorah Marks-Ohana; Eran Pras; Tamar Ben-Yosef; Hadas Newman; Menachem Gross; Anand Swaroop; Eyal Banin; Dror Sharon
Journal:  Am J Hum Genet       Date:  2016-09-01       Impact factor: 11.025

9.  Phenotype-genotype correlations in X linked retinitis pigmentosa.

Authors:  J Kaplan; A Pelet; C Martin; O Delrieu; S Aymé; D Bonneau; M L Briard; A Hanauer; L Larget-Piet; P Lefrançois
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

10.  Retinitis pigmentosa and allied conditions today: a paradigm of translational research.

Authors:  Carmen Ayuso; Jose M Millan
Journal:  Genome Med       Date:  2010-05-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.